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Abstract 
Background: Studies in animal models, in which internal hydrocephalus has been induced by obstructing the 
cerebrospinal fluid pathways, have documented an up-regulation of the concentrations of aquaporin-4 (AQP4) in the 
brain. In this study, the concentrations of aquaporin-1 (AQP1), AQP1, AQP4 and interleukin-6 (IL-6) were determined 
in the CSF of dogs with idiopathic communicating hydrocephalus before and after the reduction of intraventricular 
volume following ventriculo-peritoneal shunt (VP-shunt) treatment.
Results: The concentrations of AQP4 and IL-6 were increased in the cerebrospinal fluid of dogs with hydrocephalus 
compared to controls. Both parameters significantly decreased after surgical treatment, accompanied by decrease of 
ventricular size and the clinical recovery of the dogs. AQP1 was not detectable in CSF.
Conclusions: Brain AQP4 up-regulation might be a compensatory response in dogs with hydrocephalus. Future 
determination of AQP4 at the mRNA and protein level in brain tissue is warranted to substantiate this hypothesis.
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Background
Definitive treatment options for internal hydrocephalus 
in dogs and humans rely mostly on surgical implantation 
of CSF-draining shunt systems [1–4]. Medical treatment 
methods aiming at reducing CSF production have been 
reported to provide temporary relief of clinical signs, 
but are mostly ineffective [2, 5–7]. Therefore, improved 
medical treatment options, especially for immature 
hydrocephalic patients, are desirable. Aquaporins (AQPs) 
are a family of water channel proteins, which are found 
in cell membranes in a number of tissues, including the 
central nervous system (CNS) [8, 9]. In the brain, the 
predominant water channel is AQP4, which provides the 
molecular basis for bidirectional water transport across 
the cell membranes of the blood–brain- and blood-CSF 
boundaries. The driving force behind water movement 
can be both osmotic and hydraulic in nature, the latter 
allowing the bulk flow of water across cell membranes 
[9–11]. AQP4 is mainly located in the astrocyte foot 
processes that surround capillaries in the CNS. At this 
boundary, brain AQP4 regulates water removal from the 
pericapillary space into brain vessels suggesting it has a 
crucial role in fluid volume homeostasis [8–11].
Under certain pathological conditions changes in AQP4 
expression have been found [12–14]. Studies in animal 
models, in which internal hydrocephalus has been induced 
by injection of kaolin into the subarachnoid space, docu-
mented an up-regulation of AQP4 in the periventricular 
white matter [15, 16] and cerebral cortex [17]. Increased 
levels of soluble AQP4 were also found in the CSF of chil-
dren with naturally occurring internal hydrocephalus [18]. 
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It has been suggested that increased integration of AQP4 
into the astrocyte membranes might have a compensatory 
effect in countering excess CSF [15, 19, 20] by increased 
astroglial clearance of excess brain water by transcellular 
routes and/or through the glia limitans [16].
A second water channel in the CNS, namely AQP1, is 
reported to be limited to choroid plexus epithelia within 
the CNS. Experimental depletion of the AQP1 gene in 
mice leads to a decrease in CSF production by the choroid 
plexus, demonstrating a role for AQP1 in CSF produc-
tion [21]. The proposed adaptive and protective roles of 
AQP1 and-4 as regulators of CSF production and absorp-
tion in the pathophysiology of hydrocephalus, establishes 
these AQPs as interesting candidates for possible treat-
ment options. Interleukin 6 (IL-6) is a pro-inflammatory 
cytokine. Increased levels of IL-6 have been associated 
with periventricular white matter damage [22]. Neurons, 
astrocytes, microglia and endothelial cells are the main 
sources of IL-6 in the CNS [23]. Internal hydrocephalus 
is primarily a white matter disease and IL-6 levels may be 
used as a surrogate marker for white matter injury. Thus, 
a correlation between IL-6 and AQP4 levels could be use-
ful to indicate the extent of white matter damage.
The aim of the present study was to determine the con-
centration of AQP1and AQP4 in the CSF of dogs with 
idiopathic communicating hydrocephalus, and possible 
changes in these levels after reduction of intra-ventric-
ular pressure following ventriculo-peritoneal shunting. 
Given the previously-reported relationship between 
IL-6 and white matter damage in neonatal children and 
the presence of white matter damage in internal hydro-
cephalus, we also investigated the relationship between 
IL-6 and the aquaporins. We hypothesised that increased 
ventricular volume is positively correlated to CSF levels 
of AQP4 and IL-6, and negatively correlated to AQP1 in 
dogs with idiopathic communicating hydrocephalus.
Methods
Animals
Fourteen dogs with internal hydrocephalus, whose own-
ers decided on surgical implantation of a ventriculo-
peritoneal shunt (VP-shunt) system for permanent CSF 
drainage were prospectively selected between 2010 and 
2014. The dogs had to meet the following criteria to be 
included in the study. (1) The hydrocephalus had to be 
diagnosed as idiopathic communicating, based on mag-
netic resonance imaging (MRI) of the brain without signs 
of parenchymal contrast enhancement or visual obstruc-
tion of CSF pathways. (2) Clinical re-evaluation, with CSF 
samples taken and immediately stored at −80 °C and both 
pre- and post-operative MRIs performed in our clinic to 
allow direct comparisons. (3) Medical pre-treatment 
using drugs to reduce CSF production (glucocorticoids, 
omeprazole, acetazolamide, furosemide) excluded dogs 
from the study. (4) In the follow up MRI, a decrease in 
ventricular volume had to be demonstrated as an indica-
tion for effective shunt treatment.
CSF collection and MRI examination was also per-
formed on a control group of 10 dogs that were donated 
to the clinic after euthanasia due to non-neurological dis-
eases. CSF was taken within 2  min of death of the ani-
mals. Ventriculomegaly was an exclusion criterion for the 
dogs in this group.
Clinical evaluation
Collected data included the breed, age, gender, body-
weight, type and duration of neurological deficits before 
and after surgery. Clinical data regarding the present-
ing signs and clinical improvement of the animals after 
shunting procedures were determined by a board certi-
fied neurologist. A standardised neurologic examination 
was performed prior to, and every day after surgery until 
discharge, and again 3 months after surgery.
Magnetic resonance imaging
Diagnosis of idiopathic communicating hydrocepha-
lus was made by MRI using a 1.0 Tesla scanner (Gyros-
can Intera, Phillips, Hamburg, Germany) and a solenoid 
surface coil (C3). For the MRI examination dogs were 
premedicated with diazepam (0.5 mg/kg IV) and l-meth-
adone (0.5  mg/kg IV). Anesthesia was induced with 
propofol (4 mg/kg IV) and maintained after endotracheal 
intubation with isoflurane in oxygen. Sagittal, dorsal, and 
transverse T2-weighted, transverse FLAIR sequences, 
T1-weighted before and after intravenous administration 
of 0.2 mL/kg gadodiamide (Omniscan®) were acquired in 
all animals pre-operatively. The administration of a con-
trast agent was of course not feasible in the post-mortem 
scans in the control dogs but was useful to exclude other 
neurological diseases in the study group. T2-weighted 
transverse images of the head were chosen from the 
whole MR-dataset for image segmentation, using T2-Tur-
bospin echo sequences (TE: 120 ms, TR: 2900 ms). Slice 
thickness varied from 2–3 mm. The field of view meas-
ured 180 × 180 mm in small dogs and 210 × 210 mm in 
large dogs. The matrix was 288 × 288 in small dogs and 
384 × 384 in large dogs leading to an in-plane pixel size 
between 0.625 × 0.625 and 0.54 × 0.54 mm.
Accumulation of CSF in the lateral cerebral ventricles, 
an absent septum pellucidum, dorsal bulging of the cor-
pus callosum and dilation of the third ventricle all indi-
cated active ventricular distension and were consistent 
with hydrocephalus [24]. Patency of the mesencephalic 
aqueduct was assessed in all image planes. A clearly vis-
ible hyperintense signal (CSF) within the aqueduct and a 
non-distended 4th ventricle determined the presence of 
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communicating hydrocephalus [25]. The absence of any 
other visible lesion and lack of contrast enhancement 
within the brain parenchyma finally resulted in the diag-
nosis of idiopathic communicating hydrocephalus. MRI 
in the control group was without special findings. To 
assess the ventricular dimensions and restoration of the 
brain parenchyma, MRI was repeated 3 months after sur-
gery in the study group (Fig. 1).
Morphometric procedures
The volume of the cerebral ventricles and the brain tissue 
was determined based on the T2-weighted images. Image 
processing for volume rendering was achieved using spe-
cialised graphical software as described elsewhere [26] 
(AMIRA®, Mercury Computer Systems, Berlin, Ger-
many), which allowed manual image segmentation of the 
ventricular system and brain parenchyma on a slice-by-
slice basis. The segmented partitions were calculated and 
graphically presented by the programme (Fig. 2).
Shunting procedures
Ventriculo-peritoneal shunting was performed as 
described elsewhere [3] (Fig. 3 Lateral radiograph of dog 
with shunt in place). A gravitational ball valve was used 
in all dogs (paediGAV®, Miethke GmbH & Co KG, Pots-
dam, Germany).
CSF sampling
On the day of the diagnostic MRI, a routine CSF exami-
nation was performed (cytology and biochemical analy-
sis) to rule out inflammatory diseases of the brain. CSF 
was collected from the cisterna magna (1  mL per 5  kg 
body weight).
The first CSF specimen for AQP and IL-6 analysis was 
collected from the pumping chamber during VP-shunt 
placement. After insertion of the ventricular catheter and 
connection of the pumping chamber, CSF was allowed to 
exit the ventricles via the shunt until pulsatile flow was 
observed in the transparent chamber. Depending on 
the ventricular volume and the size of the dog, 1–2 mL 
CSF was collected and stored in plastic tubes (Eppen-
dorf tubes) at −80  °C for further analyses. The ventric-
ular catheter was routinely tested for patency: 3  h after 
emptying the chamber via transcutaneous puncture, 
the chamber was checked for refilling by repeat punc-
ture. The second CSF specimen was collected 3 months 
after shunt insertion from the subcutaneous pumping 
chamber.
Ethical approval
Approval by an ethics committee for the CSF collec-
tion was not required as all procedures are part of the 
therapeutic procedure or routine diagnostic workup of 
clinical patients [German Animal Experiment Act [“Tier-
schutzgesetz”], paragraph 9.2]. Verbal approval to exam-
ine the CSF for research purposes was obtained from the 
owners.
CSF AQP1, AQP4, and IL‑6 measurements
Frozen CSF specimens were evaluated 4–26  months 
after sampling. A dog-specific ELISA Kit was used for 
analyses of AQP1 and AQP4 in CSF, according to the 
instructions provided by the manufacturer (Canine AQP 
ELISA kit, assay ID AQP4: E08A0467; AQP1: E08A0863, 
BlueGene Biotech, Shanghai, China). The kit applied the 
competitive immunoassay technique using a monoclo-
nal anti-AQP4-antibody and an AQP4 horseradish- per-
oxidase conjugate. Standards containing 0, 2.5, 5.0, 10, 
25 and 50 ng/mL AQP4 were used to create a standard 
curve, which was used to calculate AQP4 concentrations 
Fig. 1 Transversal T2-weighted MR-image of the brain and ventricular system of a bullterrier with internal hydrocephalus at the time of diagnosis 
(a), directly post-operatively (b), and 3 months after surgery (c) showing the reduction of the ventricular volume and reconstitution of the cerebral 
parenchyma
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in the biological samples. According to the manufactur-
er’s instructions no significant cross-reactivity or inter-
ference between AQP4 and its analogues was observed. 
The coefficient of variation within a given lot and 
between different lots was stated to be less than 10  %. 
Samples were determined in duplicate and the detection 
limit of the specific assay proved to be 0.1 ng/mL.
IL-6 concentrations were determined by a bioas-
say based on the dose-dependent growth stimulation of 
IL-6 on the B9 hybridoma cell line [27, 28]. This cell line 
requires IL-6 for survival and proliferation. The advan-
tages of the B9 assay are its extreme sensitivity and its 
feature that only bioactive molecules are measured. The 
assay was performed in sterile, 96-well microtiter plates. 
In each well, 5000 B9 cells were incubated for 72 h with 
serial dilutions of biological samples (cerebrospinal fluid) 
or with different concentrations of a human IL-6 standard 
(code 89–548, National Institute for Biological Standards 
and Control, South Mimms, UK). Samples were pre-
diluted so that serial dilutions of samples and standard 
dilution curves were made in parallel. The number of cells 
in each well was measured by the dimethylthiazol-diphe-
nyl tetrazolium bromide (MTT) colorimetric assay [27]. 
The detection limit of the assay, after considering the dilu-
tion of samples, was set at 3 international units (IU)/mL.
Statistical analysis
All data was analysed using a statistical software pack-
age (Graph Pad Prism 4.0, Graph Pad Software Inc., 
San Diego, California). AQP and IL-6 concentration 
before and after surgery were compared with controls. 
CSF volume before and after surgery may not only be 
dependent on ventricular distension, but also on the 
size of the dog (1.2–20 kg, see Table 1, Epidemiological 
data and clinical signs) as this also influences ventricu-
lar volume. Therefore, we considered that the concen-
trations of AQP4 and IL-6 could also be influenced by 
CSF volume. To take these morphological differences 
into account, the concentration of AQPs (ng/mL) and 
IL-6 (IU/mL) were additionally multiplied by the total 
ventricular volume (expressed as total AQP/-IL-6 quan-
tity) to calculate the total amounts of AQPs and IL-6 in 
the ventricles.
After assessment of the normal distribution of this data 
using the Shapiro–Wilk test, one-way ANOVA was used 
to test for global differences between the mean concen-
tration and total AQP4 quantity as well as the ventricular 
volume before and after surgery. If significant differences 
between the groups were present, post hoc Tukey`s test 
for multiple comparisons was used to reveal differences 
between all pairs of groups. IL-6 concentration and total 
IL-6 quantity were not normally distributed. They were 
tested for global differences using a Kruskal–Wallis test 
followed by a post hoc Dunn’s multiple comparison test.
Correlation between AQP4 and IL-6 concentra-
tion in the preoperative CSF specimen was tested using 
Spearman`s correlation. Association of AQP4 and IL-6 
with ventricular reduction was tested using the Chi 
Fig. 2 Volumetric determination of the brain and ventricular volume of a control dog (a) in contrast to a hydrocephalic dog from the study group 
(b). The brain parenchyma is transparent, allowing the view of the ventricular system
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square test. P values less than 0.05 were considered to be 
statistically significant (95 % confidence interval).
Results
Animals and clinical examination
Breed, age, sex, clinical signs and duration of clinical 
signs are summarised in Table 1 (Study group dogs) and 
Table 3 (Control dogs). Two dogs were excluded from the 
study group because there was no postoperative reduc-
tion of ventricular volume.
CSF analysis
Results of CSF analyses are presented in Table  2 (study 
group dogs) and Table 3 (control dogs).
AQP4
Results of group comparisons are summarised in Fig. 4. 
The mean concentration of AQP4 was globally different 
between groups (P  <  0.0127). Post hoc tests revealed a 
significant difference between the mean AQP4 concen-
trations before (11.32 ng/mL), and after surgery (9.3 ng/
mL; P < 0.01), and before surgery compared to controls 
(9.5  ng/mL; P  <  0.01). Postoperative AQP4 concen-
trations were not significantly different from controls 
(P > 0.05).
Total AQP4 quantities were globally different 
between groups (P  <  0.0001). The mean total AQP4 
quantity (325.8  ng) in dogs with internal hydrocepha-
lus before surgery was significantly different from con-
trol dogs (32.12 ng, P < 0.0001). After shunting, mean 
total AQP4 quantity was significantly different from 
pre-operative values (60.49 ng, P < 0.0001), but not dif-
ferent from controls (P > 0.05). CSF volume was signifi-
cantly reduced after surgery (P < 0.001). A reduction of 
ventricular volume was associated with AQP4 decrease 
(P < 0.001).
AQP1
AQP1 levels remained below the detection limit in all 
CSF samples analysed. Using an AQP1 ELISA kit and the 
same procedure as for AQP4, OD values were around 
zero.
IL‑6
IL-6 concentrations (Fig.  4) were globally different 
between the groups (P < 0.0036). The median IL-6 con-
centrations before surgery (62  IU/mL) was significantly 
higher than postoperative values (34  IU/mL; P  <  0.001) 
and higher when compared to controls (26  IU/mL; 
P  <  0.001). Postoperative values were not different to 
Fig. 3 Laterolateral radiograph of the head and neck of a bullterrier after ventriculo-peritoneal shunting showing the proximal components and 
course of the shunt system
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controls (P  >  0.05). Total IL-6 quantities were signifi-
cantly different between groups (P < 0.0001). Total IL-6 
quantities were significantly higher in dogs with internal 
hydrocephalus than in control dogs before surgery (1083 
vs. 86.3 IU; P < 0.0001) and significantly decreased after 
shunting (149.3 IU; P < 0.0001), but were still significantly 
higher than in the control group (P < 0.01).
Concentrations of AQP4 and IL-6 measured in 
the preoperative CSF specimens were not correlated 
(P = 0.449).
Discussion
We found increased AQP4 and IL-6 concentrations in the 
CSF of dogs with idiopathic communicating hydrocepha-
lus. AQP4 and IL-6 concentrations decreased signifi-
cantly after reduction of lateral ventricular volume using 
an indwelling ventriculo-peritoneal shunt system. Up-
regulation of AQP4 channels has been documented in a 
variety of pathological processes in the brain that result 
in fluid overload, including internal hydrocephalus. In 
rats with inherited [19] and kaolin-induced hydrocepha-
lus [15], an increase in AQP4 mRNA- and protein lev-
els within the periventricular parenchyma was reported 
post-induction. It seems likely that the increase in AQP4 
reflects the development of an alternative pathway for 
parenchymal CSF absorption [9, 15–17, 19, 20]. This 
notion is also supported by the observation that AQP4 
null mice exhibit a more severe form of hydrocephalus 
with larger ventricular distension and pressure elevation 
after kaolin injection, than mice with unimpaired AQP4 
expression [29]. Whereas AQP4 changes have been well 
described in experimentally-induced hydrocephalus, few 
publications have studied the association between AQPs 
and naturally-occurring hydrocephalus. This is impor-
tant in that hydrocephalus is usually non-communicating 
in laboratory rodents, but communicating in the dogs 
reported in the present study. Hence, there are more 
similarities between human and canine communicat-
ing hydrocephalus, when compared to experimentally-
induced hydrocephalus after intrathecal kaolin injection 
in rodents and the subsequent inflammatory reaction. It 
has been shown in dogs with induced hydrocephalus that 
after an initial rise, CSF pressure can return to normal 
levels as the ventricles enlarge [30].
In the classic model of CSF physiology in dogs the fluid 
is produced by the choroid plexus [31]. The primary sites 
of reabsorption are the arachnoid projections from the 
subarachnoid space into the sagittal dural venous sinus. 
There is evidence that extracellular fluid (ECF) from the 
brain parenchyma essentially contributes to CSF produc-
tion and its bulk flow within the central nervous system 
[32]. Under normal conditions, arterial pulsation drives 
the ECF toward the veins and towards the ventricles in 
humans and dogs. It has been suggested that this physi-
ological ECF flow is reduced in hydrocephalus, and the 
pericapillary space has been confirmed as playing a criti-
cal role in the reabsorption of ECF [9, 33]. The ependy-
mal lining is frequently destroyed in hydrocephalus [34] 
and AQP4 can, therefore, leak more easily from the 
parenchyma to the CSF via the ECF [18].
Table 1 Epidemiological data and results of pre- and postoperative clinical examination of the study group
Number Breed Gender, age, bodyweight Clinical signs Postoperative clinical signs
1 Boston terrier Male, 3 months old, 2.5 kg Obtundation, mild ataxia on all four 
limbs, circling, aimless barking
None
2 Mini Australian shepherd Male-neutered, 26 months old,  
12.5 kg
Visual deficits, reduced menace, 
circling
Visual deficits, reduced menace
3 Peruvian hairless dog Male, 2 months old, 2.8 kg Ataxia on all four limbs, ventro-lateral 
strabismus, obtundation
None
4 Austrian hound Male, 54 months old, 20 kg Obtundation, circling, head tremor, 
hypermetria in the front limbs
None
5 Cavalier King Charles spaniel Male neutered, 60 months old, 9.9 kg Obtundation None
6 Pug Male, 21 months old, 9.2 kg Obtundation, ataxia on all four limbs None
7 Papillon Female, 7 months old 3.4 kg Obtundation, ataxia, head tilt tremor None
8 Chihuahua Male neutered, 3 months old, 1.2 kg Obtundation, mild ataxia, spasticity 
in all four limbs, reduced menace 
response
None
9 Australian shepherd Male, 4 months old, 13.9 kg Visual deficits. reduced menace, 
nystagmus, hypoactive
Visual deficits, reduced menace
10 Jack Russell terrier Male, 4 months old, 4.7 kg Obtundation, ataxia on all four limbs None
11 Bullterrier Female, 25 months old 12.5 kg Intermittent obtundation, head 
pressing
None
12 Maltese mix Male neutered, 6 months old, 6.1 kg Circling, obtundation None
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Table 2 Pre and post-operative concentrations for aquaporin 4 and interleukin 6 and CSF volumes for dogs with hydro-
cephalus
Dog  
number
Routine CSF  
examination
Pre‑operative values AQP4 (ng/mL),  
total AQP4 (ng), IL‑6 (IU/mL)  
total IL‑6 (IU), CSF volume (mL)
Postoperative values AQP4 (ng/mL), 
total AQP4 (ng), IL‑6 (IU/mL), total 
IL‑6 (IU), CSF volume (mL)
1 Protein 252 mg/L
RBC 0/μL
Cells 3/μL
AQP4 12.78
Total AQP4 quantity 301.5
IL-6 63
Total IL-6 quantity 1486.8
CSF volume 23.6
AQP4 10.81
Total AQP4 quantity 28.51
IL-6 30
Total IL-6 quantity 84
CSF volume 2.8
2 Protein 276 mg/L
RBC 280/μL
Cells 1/μL
AQP4 10.77
Total AQP4 quantity 223.5
IL-6 87
Total IL-6 quantity 2260.8
CSF volume 26.4
AQP4 10.2
Total AQP4 quantity 27.99
IL6 36
Total IL-6 quantity 96.62
CSF volume 2.6
3 Protein 276 mg/L
RBC 291/μL
Cells 5/μL
AQP4 17.47
Total AQP4 quantity 391.33
IL-6 22
Total IL-6 quantity 492.8
CSF volume 22.4
AQP4 14.23
Total AQP4 quantity 150
IL-6 15
Total IL-6 quantity 61.1
CSF volume 10.6
4 Protein 240 mg/L
RBC 0/μL
Cells 1/μL
AQP4 15.29
Total AQP4 quantity 455.56
IL-6 28
Total IL-6 quantity 834.4
CSF volume 29.8
AQP 49.71
Total AQP4 quantity 45.62
IL-6 13
Total IL-6 quantity 634.5
CSF volume 4.7
5 Protein 240 mg/L
RBC 0/μL
Cells 5/μL
AQP4 13.51
Total AQP4 quantity 278.3
IL-6 39
Total IL-6 quantity 803.4
CSF volume 20.6
AQP4 5.3
Total AQP4 quantity 34.45
IL-6 21
Total IL-6 quantity 136.5
CSF volume 6.5
6 Protein 208 mg/L
RBC 0/μl
Cells 1/μl
AQP4 10.33
Total AQP4 quantity 133.3
IL-6 51
Total IL-6 quantity 658.41
CSF volume 12.91
AQP4 9.9
Total AQP4 quantity 63.67
IL-6 32
Total IL-6 quantity 205.76
CSF volume 6.43
7 Blood contamination AQP4 17.96
Total AQP4 quantity 467.67
IL-6 87
Total IL-6 quantity 2265.48
CSF volume 26.04
AQP4 8.93
Total AQP4 quantity 21.43
IL-6 37
Total IL-6 quantity 88.8
CSF volume 2.4
8 Protein 246 mg/L
RBC 15/μL
Cells 5/μL
AQP4 8.46
Total AQP4 quantity 211.54
IL-6 62
Total IL-6quantity 1078.8
CSF volume 17.4
AQP4 10.77
Total AQP4 quantity 3.95
IL-6 21
Total IL-6 quantity 13.4
CSF volume 1.64
9 Blood contamination AQP4 12.16
Total AQP4 quantity 472.45
IL-6 65
Total IL-6 quantity 1709.5
CSF volume 26.3
AQP4 2.41
Total AQP4 quantity 58.03
IL-6 40
Total IL-6 quantity 260
CSF volume 6.5
10 Protein 300.9 mg/L
RBC 18/μL
Cells 7/μL
AQP4 19.19
Total AQP4 quantity 675.31
IL-6 66
Total IL-6 quantity 2323.2
CSF volume 35.2
AQP4 9.67
Total AQP4 quantity 190.95
IL-6 69
Total IL-6 quantity 1362.75
CSF volume:19.7
11 Protein 374 mg/L
RBC 1/μL
Cells 1/μL
AQP4 14.63
Total AQP4 quantity 168.85
IL-6 54
Total IL-6 quantity 623.16
CSF volume 11.54
AQP4 16.2
Total AQP4 quantity 58.31
IL-6 45
Total IL-6 quantity 162
CSF volume 3.6
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It remains unclear however, whether the increased 
AQP4 levels in the CSF of hydrocephalic dogs and 
humans is an unspecific finding related simply to the 
destruction of cell membranes. In this scenario, on the 
one hand, an increase of AQP4 would be a pure epiphe-
nomenon reflecting damage to the structural integrity 
of the ependyma [35] and periventricular white mat-
ter. This might be the more likely cause of the increase 
in AQP4 in the CSF. On the other hand, it has also been 
suggested that higher AQP4 levels could also be a reflec-
tion of increased production and turnover of the protein 
and its release into the interstitial space and ventricular 
Table 2 continued
Dog  
number
Routine CSF  
examination
Pre‑operative values AQP4 (ng/mL),  
total AQP4 (ng), IL‑6 (IU/mL)  
total IL‑6 (IU), CSF volume (mL)
Postoperative values AQP4 (ng/mL), 
total AQP4 (ng), IL‑6 (IU/mL), total 
IL‑6 (IU), CSF volume (mL)
12 Protein 204 mg/L
RBC 0/μL
Cells 4/μL
AQP4 7.1
Total AQP4 quantity 130.14
IL-6 89
Total IL-6 quantity 1631
CSF volume 18.33
AQP4 4.5
Total AQP4 quantity 42.93
IL-6 46
Total IL-6 quantity 438.84
CSF volume 9.54
Pre-, and post-operative determination of the ventricular volume (CSF volume), aquaporin-4 (AQP4) and interleukin-6 (IL-6) of the study group of 12 dogs with 
hydrocephalus. AQP4 and IL-6 have been multiplied by the total CSF volume, to give the total quantity in the CSF. The underlined entries (dogs 8 and 11) are dogs in 
which no decrease of AQP4 and IL-6 concentration was found after surgery although the total quantities were decreased (CSF cerebrospinal fluid, RBC red blood cell 
count)
Table 3 Epidemiological data and CSF analysis in the control group
CSF volume, aquaporin-4 (AQP4) and interleukin-6 (IL-6) concentrations in the control group. Both values have been multiplied with the total CSF volume, expressed 
as AQP4* and IL-6* to obtain the total quantity in CSF (CSF cerebrospinal fluid, RBC red blood cell count)
Breed, age, gender, body weight Routine CSF  
examination
CSF volume  
(mL)
AQP4 concentrations 
and total quantity
IL‑6 concentrations 
and total quantity
Pug, 4 years male neutered, 4.6 kg Protein 262 mg/L
RBC 0/μL
Cells 3/μL
2.4 AQP4: 11.25
Total AQP4 quantity 27
IL-6: 25 IU
Total IL-6 quantity 60
Dachshund, 9 years, male, 6 kg Protein 256 mg/L
RBC 0/μL
Cells 1/μL
3.2 AQP4: 9.67
Total AQP4 quantity 30.94
IL-6: 24 IU
Total IL-6 quantity 76.8
Austrian hound, 3 years male, 26 kg Protein 220 mg/L
RBC 0/μL
Cells 3/μL
3.14 AQP4: 9.0
Total AQP4 quantity 28.26
IL-6: 27 IU
Total IL-6 quantity 85.87
German Shepherd dog, male,  
5 years, 22 kg
Protein 302 mg/L
RBC 0/μL
Cells 2/μL
4.2 AQP4: 12.33
Total AQP4 quantity 51.78
IL-6: 19 IU
Total IL-6 quantity 79.8
Beagle, male-neutered 2 years, 12 kg Protein 286 mg/L
RBC 0/μL
Cells 1/μL
2.45 AQP4: 8.87
Total AQP4 quantity 21.74
IL-6: 42 IU
Total IL-6 quantity 102.9
Doberman, male, 4 years, 36 kg Protein 120 mg/L
RBC 0/μL
Cells 1/μL
3.04 AQP4: 6.57
Total AQP4 quantity 19.97
IL-6: 20 IU
Total IL-6 quantity 60.8
French Bulldog female-neutered,  
1,5 years, 8 kg
Protein 79 mg/L
RBC 0/μL
Cells 2/μL
3.4 AQP4: 9.1
Total AQP4 quantity 30.60
IL-6: 27 IU
Total IL-6 quantity 91.8
Bernese mountain dog, female,  
6 years, 34 kg
Protein 265 mg/L
RBC 0/μL
Cells 3/μL
4 AQP4: 11.97
Total AQP4 quantity 47.86
IL-6: 22 IU
Total IL-6 quantity 88
Cavalier King Charles spaniel,  
female, 8 years, 6 kg
Protein 289 mg/L
RBC 0/μL
Cells 5/μL
3.2 AQP4: 11.52
Total AQP4 quantity 36.87
IL-6: 34 IU
Total IL-6 quantity 108.8
Doberman, female- neutered,  
7 years, 29 kg
Protein 156 mg/L
RBC 0/μL
Cells 1/μL
3.21 AQP4: 8.03
Total AQP4 quantity 25.79
IL-6: 55 IU
Total IL-6 quantity 176.55
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system. Such shedding of membrane proteins has been 
documented for renal AQPs. Wen et al. [36] showed that 
urinary excretion of AQP2 occurs under physiological 
conditions as part of its increased integration into the 
apical membrane of the collecting duct after vasopressin 
stimulation. During this process AQP2 is excreted into 
the urine in a proportion specific to the quantity of mem-
brane-bound AQP [37–40].
It has been shown that distension of the ventricles and 
compression of periventricular white matter capillaries are 
accompanied by pro-inflammatory cytokine activation. 
Damage to the periventricular white matter is the main 
impact on brain integrity in hydrocephalus cases [34, 41]. 
IL-6 has been associated with periventricular white mat-
ter injury in newborn babies with peripartal hypoxia [22] 
and increases in IL-6 and IL-8 were more pronounced in 
Fig. 4 Box and Whisker diagrams demonstrating differences in the mean/median, 25/75 % percentile and minimum-maximum of the, aquaporin-4 
(AQP4) and interleukin-6 (IL6) concentrations in the cerebrospinal fluid before and 3 months after surgery compared to controls (top row). The total 
quantity of both parameters AQP4 and IL6 (middle row) was calculated by multiplying by the ventricular volume (bottom graph). Significant differ-
ences are marked with asterisks (*P < 0.01; **P <0.001; ***P < 0.0001, n = 14, 14, 10 for preoperative, postoperative and control groups, respectively
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the infants with a severe clinical course [42]. A correla-
tion between IL-6 levels and white matter integrity has 
been documented in elderly humans [43, 44]. We there-
fore consider that changes in IL-6 concentrations in the 
CSF act as a surrogate marker for white matter injury in 
the present study. Here, it has become evident that AQP4 
concentration was not correlated with IL-6 concentra-
tion in CSF taken preoperatively. This observation might 
favour the notion that CSF AQP4 level does not merely 
reflect white matter damage, however, the exact circum-
stances between pressure rise and AQP4 changes in the 
CSF remain to be further analysed in future studies.
Our study also showed that adjusting the concentra-
tions of AQP4 and IL-6 to the total CSF volume was not 
necessary to detect significant differences in AQP4 and 
IL-6 concentrations. Following the rationale that CSF is 
constantly produced and the amount of the solute may 
depend on the amount of the total solvent (CSF), we con-
sidered it might be necessary to calculate AQP4 and IL-6 
total quantities by multiplying by the ventricular volume. 
Although preoperative volumes in some dogs exceeded 
three times the volume of other hydrocephalic dogs, the 
differences in ventricular dimensions did not obscure 
differences in CSF AQP4 concentrations. In fact, the 
concentrations were comparable to those measured in 
children with hydrocephalus (13.3 in dogs vs. 11.32.ng/
mL in children), as well as those in normal dogs to the 
values in unaffected children (9.5 in dogs vs. 8.61 ng/mL 
in children) [18].
The main limitation of this study is therefore the heter-
ogeneity of the examined dogs. Different dog breeds were 
examined without knowledge of the underlying cause of 
the CSF accumulation or of intraventricular pressure, 
with different degrees of ventricular dilatation and differ-
ent durations of clinical signs. Dogs with hydrocephalus 
were younger than control dogs. Furthermore, CSF from 
the control group was taken after euthanasia and also not 
from the intraventricular site, which might also have a 
potential influence on measured AQP4 and IL-6 levels.
While we were able to measure AQP4 in the CSF of 
normal and hydrocephalic dogs, AQP1 levels were below 
the detection limit in all samples. Interestingly, analysis 
of AQP1 expression after the induction of hydrocephalus 
in rodents has revealed conflicting results. In mice, it has 
been shown that AQP1 is down-regulated after induc-
tion of hydrocephalus, rather suggesting a compensatory 
response to hydrocephalus [41], however, another study 
showed unchanged AQP1 expression in a rat model of 
hydrocephalus [15]. Being confined to the choroid plexus, 
AQP1 expression is much lower than AQP4 expression 
in the rodent brain and CSF. This is also reflected in the 
fact that values remained below the detection limit in our 
current analyses for canine CSF AQP1.
Conclusions
An increase in ventricular dimension is accompanied by 
increases in AQP4 and IL-6 concentrations in the CSF 
of dogs with idiopathic communicating hydrocephalus. 
All were greatly reduced or normalised after shunt treat-
ment. Therefore AQP4 and IL-6 in CSF can be indicators 
of ventriculomegaly, of cellular damage, and of improve-
ment after the treatment of hydrocephalus. Based on 
the results of this study, a brain tissue-based determina-
tion of AQP4 at the mRNA and protein level might be 
rewarding to analyse the potential role of AQP4 in the 
compensation of extracellular fluid overload in dogs with 
communicating hydrocephalus.
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